Cargando…
Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment
SIMPLE SUMMARY: The use of neoadjuvant therapy (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) is increasing. Objective quantification of the histopathological response to NAT may be used to guide adjuvant treatment and compare the efficacy of neoadjuvant regimens. However, current tu...
Autores principales: | Janssen, Boris V., Theijse, Rutger, van Roessel, Stijn, de Ruiter, Rik, Berkel, Antonie, Huiskens, Joost, Busch, Olivier R., Wilmink, Johanna W., Kazemier, Geert, Valkema, Pieter, Farina, Arantza, Verheij, Joanne, de Boer, Onno J., Besselink, Marc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533716/ https://www.ncbi.nlm.nih.gov/pubmed/34680241 http://dx.doi.org/10.3390/cancers13205089 |
Ejemplares similares
-
The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
por: Zwart, Eline S., et al.
Publicado: (2023) -
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)
por: Janssen, Boris V, et al.
Publicado: (2022) -
The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis
por: de Bakker, Jacob, et al.
Publicado: (2022) -
Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma
por: Meijer, Laura L, et al.
Publicado: (2020) -
The use of ChatGPT and other large language models in surgical science
por: Janssen, Boris V, et al.
Publicado: (2023)